stella
beta
Bolstering Outcomes After Induction With Osimertinib Plus Chemotherapy Through Optimized Site-Directed Primary Tumor Therapy (BOOST Trial) — Stella
Recruiting
Back to Non-Small Cell Lung Cancer trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
South Korea
Pusan National University Hospital, Busan
View full record on ClinicalTrials.gov